Mechanisms of Bone Impairment in Sickle Bone Disease
Open Access
- 13 February 2021
- journal article
- review article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (4), 1832
- https://doi.org/10.3390/ijerph18041832
Abstract
Sickle bone disease (SBD) is a chronic and invalidating complication of Sickle cell disease (SCD), a multisystem autosomal recessive genetic disorder affecting millions of people worldwide. Mechanisms involved in SBD are not completely known, especially in pediatric age. Among the hypothesized pathogenetic mechanisms underlying SBD are bone marrow compensatory hyperplasia and bone ischemic damage, both secondary to vaso-occlusive crisis (VOC), which leads to cell sickling, thus worsening local hypoxia with a negative impact on osteoblast recruitment. Furthermore, the hypoxia is a strong activator of erythropoietin, which in turn stimulates osteoclast precursors and induces bone loss. Hemolysis and iron overload due to a chronic transfusion regimen could also contribute to the onset of bone complications. Vitamin D deficiency, which is frequently seen in SCD subjects, may worsen SBD by increasing the resorptive state that is responsible for low bone mineral density, acute/chronic bone pain, and high fracture risk. An imbalance between osteoblasts and osteoclasts, with a relative decrease of osteoblast recruitment and activity, is a further possible mechanism responsible for the impairment of bone health in SCD. Moreover, delayed pubertal growth spurt and low peak bone mass may explain the high incidence of fracture in SCD adolescents. The aim of this review was to focus on the pathogenesis of SBD, updating the studies on biochemical, instrumental, and biological markers of bone metabolism. We also evaluated the growth development and endocrine complications in subjects affected with SCD.Keywords
This publication has 69 references indexed in Scilit:
- Postmenopausal Osteoporosis: The Role of Immune System CellsJournal of Immunology Research, 2013
- Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimatesThe Lancet, 2013
- Risk Factors for Subclinical Atherosclerosis in Diabetic and Obese ChildrenInternational Journal of Medical Sciences, 2013
- Predictors of osteoclast activity in patients with sickle cell diseaseHaematologica, 2011
- Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesisNature Communications, 2010
- Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination SurveyOsteoporosis International, 2010
- Cellular and Molecular Mechanisms of Bone RemodelingJournal of Biological Chemistry, 2010
- Demographic Differences and Trends of Vitamin D Insufficiency in the US Population, 1988-2004JAMA Internal Medicine, 2009
- Markers of bone turnover are associated with growth and development in young subjects with sickle cell anemiaPediatric Blood & Cancer, 2008
- Vertebral fracture assessment using a semiquantitative techniqueJournal of Bone and Mineral Research, 1993